Akkermansia Company acquired by Danone

The Akkermansia Company, or TAC, announces that it has been acquired by Danone (DANOY). “TAC’s founding scientists first discovered the biotic strain Akkermansia muciniphila MucT in 2004 and have since developed it using state-of-the-art technology. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes and cardiovascular disease. The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form. TAC is successfully expanding business into key markets in Europe, North America and Asia,” the company stated. Michael Oredsson, CEO of TAC, added: “We are very excited about becoming part of the Danone family. It provides us with the resources to accelerate global growth of the pasteurized Akkermansia muciniphila MucT strain and develop our brands faster.”